FDA CONDITIONALLY APPROVES MERCK ANIMAL HEALTH'S EXZOLT™ CATTLE-CA1 FOR THE PREVENTION AND TREATMENT OF NEW WORLD SCREWWORM (COCHLIOMYIA HOMINIVORAX) LARVAE (MYIASIS)

Reuters · 1d ago

Please log in to view news